Cargando…
Inflammatory Bowel Disease during COVID-19 Pandemic: A Prospective Cohort Study of Incidence Rate and Patients’ Concerns
BACKGROUND: During the coronavirus disease 2019 (COVID-19) pandemic, it is imperative to focus on the concerns of patients with chronic diseases regarding the influence of such conditions and medications prescribed for this purpose on their susceptibility to COVID-19 and its severity. This study aim...
Autores principales: | Bagheri Lankarani, Kamran, Roozitalab, Marjan, Gholami, Zahra, Yousefi, Mohammad, Ghahramani, Sulmaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Association of Gastroerterology and Hepatology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489320/ https://www.ncbi.nlm.nih.gov/pubmed/36619720 http://dx.doi.org/10.34172/mejdd.2022.252 |
Ejemplares similares
-
The cost of illness analysis of inflammatory bowel disease
por: Pakdin, Majid, et al.
Publicado: (2023) -
What do hospital doctors and nurses think wastes their
time?
por: Bagheri Lankarani, Kamran, et al.
Publicado: (2019) -
Risk Factors Affecting 90-day Readmission of Patients with Inflammatory Bowel Disease
por: Ghahramani, Sulmaz, et al.
Publicado: (2022) -
Does “Overall Catastrophic Health Care Expenditure” Make Sense?
por: BAGHERI LANKARANI, Kamran, et al.
Publicado: (2018) -
Inpatient Out-of-Pocket in Iran After Health Transformation Plan
por: Ghahramani, Sulmaz, et al.
Publicado: (2018)